Virus-like particle vaccines for norovirus gastroenteritis

Molecular Vaccines

Volumn 1, Issue , 2013, Pages 153-181

  Chen, Qiang ^a,b  

^a Arizona State University   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84899561933     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-7091-1419-3_8     Document Type: Chapter

References (150)

1. Clark, B., McKendrick, M. A review of viral gastroenteritis. Curr. Opin. Infect. Dis. 17, 461-469 (2004
2. Kapikian, A.Z. Overview of gastroenteritis. Arch. Virol. Suppl. 12, 7-19 (1996
3. Greenberg, H.B., et al. Role of Norwalk virus in outbreaks of nonbacterial gastroenteritis. J. Infect. Dis. 139, 564-568 (1979
4. Patel, M.M., Hall, A.J., Vinje, J., Parashar, U.D. Noroviruses: a comprehensive review. J. Clin. Virol. 44, 1-8 (2009
5. Green, K. Y., Chanock, R. M., Kapikian, A. Z. Caliciviridae: The Noroviruses. In Howley, P. M., Knipe, D. M. (eds) Fields virology, Ch. 28, pp. 949-979. Lippincott, Williams & Wilkins, (2007
6. Dolin, R., et al. Biological properties of Norwalk agent of acute infectious nonbacterial gastroenteritis. Proc. Soc. Exp. Biol. Med. 140, 578-583 (1972
7. Kapikian, A.Z., et al. Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis. J. Virol. 10, 1075-1081 (1972
8. Chen, R., Neill, J.D., Estes, M.K., Prasad, B.V. X-ray structure of a native calicivirus: structural insights into antigenic diversity and host specificity. Proc. Natl. Acad. Sci. U.S.A. 103, 8048-8053 (2006
9. Duizer, E., et al. Laboratory efforts to cultivate noroviruses. J. Gen. Virol. 85, 79-87 (2004
10. Green, S.M., Lambden, P.R., Caul, E.O., Ashley, C.R., Clarke, I.N. Capsid diversity in small roundstructured viruses: molecular characterization of an antigenically distinct human enteric calicivirus. Virus Res. 37, 271-283 (1995
11. Lewis, D., Ando, T., Humphrey, C.D., Monroe, S.S., Glass, R.I. Use of solid-phase immune electron microscopy for classification of Norwalk-like viruses into six antigenic groups from 10 outbreaks of gastroenteritis in the United States. J. Clin. Microbiol. 33, 501-504 (1995
12. Okada, S., et al. Antigenic characterization of small, round-structured viruses by immune electron microscopy. J. Clin. Microbiol. 28, 1244-1248 (1990
13. Wyatt, R.G., et al. Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers. J. Infect. Dis. 129, 709-714 (1974
14. Ando, T., Noel, J.S., Fankhauser, R.L. Genetic classification of Norwalk-like viruses. J. Infect. Dis. 181 (Suppl 2), S336-S348 (2000
15. Zheng, D.P., et al. Norovirus classification and proposed strain nomenclature. Virology 346, 312-323 (2006
16. Scipioni, A., Mauroy, A., Vinje, J., Thiry, E. Animal noroviruses. Vet. J. 178, 32-45 (2008
17. Zheng, D.P., Widdowson, M.A., Glass, R.I., Vinje, J. Molecular epidemiology of genogroup II-genotype 4 noroviruses in the United States between 1994 and 2006. J. Clin. Microbiol. 48, 168-177 (2010
18. Lindesmith, L.C., et al. Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med. 5, e31 (2008
19. Jiang, X., Wang, M., Wang, K., Estes, M.K. Sequence and genomic organization of Norwalk virus. Virology 195, 51-61 (1993
20. Hardy, M.E. Norovirus protein structure and function. FEMS Microbiol. Lett. 253, 1-8 (2005
21. Chaudhry, Y., et al. Caliciviruses differ in their functional requirements for eIF4F components. J. Biol. Chem. 281, 25315-25325 (2006
22. Jiang, X., Graham, D.Y., Wang, K.N., Estes, M.K. Norwalk virus genome cloning and characterization. Science 250, 1580-1583 (1990
23. Prasad, B.V., et al. X-ray crystallographic structure of the Norwalk virus capsid. Science 286, 287-290 (1999
24. Bertolotti-Ciarlet, A., Crawford, S.E., Hutson, A.M., Estes, M.K. The 3' end of Norwalk virus mRNA contains determinants that regulate the expression and stability of the viral capsid protein VP1: a novel function for the VP2 protein. J. Virol. 77, 11603-11615 (2003
25. Chakravarty, S., Hutson, A.M., Estes, M.K., Prasad, B.V. Evolutionary trace residues in noroviruses: importance in receptor binding, antigenicity, virion assembly, and strain diversity. J. Virol. 79, 554-568 (2005
26. Tan, M., Hegde, R.S., Jiang, X. The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors. J. Virol. 78, 6233-6242 (2004
27. Lochridge, V.P., Jutila, K.L., Graff, J.W., Hardy, M.E. Epitopes in the P2 domain of norovirus VP1 recognized by monoclonal antibodies that block cell interactions. J. Gen. Virol. 86, 2799-2806 (2005
28. Nilsson, M., et al. Evolution of human calicivirus RNA in vivo: accumulation of mutations in the protruding P2 domain of the capsid leads to structural changes and possibly a new phenotype. J. Virol. 77, 13117-13124 (2003
29. Glass, R.I., Parashar, U.D., Estes, M.K. Norovirus gastroenteritis. N. Engl. J. Med. 361, 1776-1785 (2009
30. Beersma, M.F., et al. Unrecognized norovirus infections in health care institutions and their clinical impact. J. Clin. Microbiol. 50, 3040-3045 (2012
31. Chen, Q., Lai, H. Plant-derived virus-like particles as vaccines. Hum. Vaccin. Immunother. 9 (2013
32. Teunis, P.F., et al. Norwalk virus: Virus-like particle (VLP) Vaccines how infectious is it?. J. Med. Virol. Marcel Dekker 80, 1468-1476 (2008
33. Estes, M K. Levine, M. M. (Ed) New Generation Vaccines, Pp. 283-294. Academic Press (2004
34. Dolin, R. Noroviruses-challenges to control. N. Engl. J. Med. 357, 1072-1073 (2007
35. Bresee, J.S., Widdowson, M.A., Monroe, S.S., Glass, R.I. Foodborne viral gastroenteritis: challenges and opportunities. Clin. Infect. Dis. 35, 748-753 (2002
36. Fankhauser, R.L., et al. Epidemiologic and molecular trends of Norwalk-like viruses associated with outbreaks of gastroenteritis in the United States. J. Infect. Dis. 186, 1-7 (2002
37. Widdowson, M.A., et al. Outbreaks of acute gastroenteritis on cruise ships and on land: identification of a predominant circulating strain of norovirus-United States, 2002. J. Infect. Dis. 190, 27-36 (2004
38. Rockx, B., et al. Natural history of human calicivirus infection: a prospective cohort study. Clin. Infect. Dis. 35, 246-253 (2002
39. Anderson, A.D., et al. Multistate outbreak of Norwalk-like virus gastroenteritis associated with a common caterer. Am. J. Epidemiol. 154, 1013-1019 (2001
40. Atmar, R.L., et al. Norwalk virus shedding after experimental human infection. Emerg. Infect. Dis. 14, 1553-1557 (2008). doi: 10.3201/eid1410.080117
41. Siebenga, J.J., et al. High prevalence of prolonged norovirus shedding and illness among hospitalized patients: a model for in vivo molecular evolution. J. Infect. Dis. 198, 994-1001 (2008
42. Patterson, T., Hutchings, P., Palmer, S. Outbreak of SRSV gastroenteritis at an international conference traced to food handled by a post-symptomatic caterer. Epidemiol. Infect. 111, 157-162 (1993
43. Khanna, N., Goldenberger, D., Graber, P., Battegay, M., Widmer, A.F. Gastroenteritis outbreak with norovirus in a Swiss university hospital with a newly identified virus strain. J. Hosp. Infect. 55, 131-136 (2003
44. Nygard, K., et al. Emerging genotype (GGIIb) of norovirus in drinking water, Sweden. Emerg. Infect. Dis. 9, 1548-1552 (2003
45. Hansen, S., et al. Closure of medical departments during nosocomial outbreaks: data from a systematic analysis of the literature. J. Hosp. Infect. 65, 348-353 (2007
46. Mounts, A.W., et al. Cold weather seasonality of gastroenteritis associated with Norwalk-like viruses. J. Infect. Dis. 181 (Suppl 2), S284-S287 (2000
47. Lopman, B., et al. Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant. Lancet 363, 682-688 (2004
48. Marshall, J.A., et al. Incidence and characteristics of endemic Norwalk-like virus-Associated gastroenteritis. J. Med. Virol. 69, 568-578 (2003
49. Nordgren, J., Bucardo, F., Dienus, O., Svensson, L., Lindgren, P.E. Novel light-upon-extension real-Time PCR assays for detection and quantification of genogroup I and II noroviruses in clinical specimens. J. Clin. Microbiol. 46, 164-170 (2008
50. Gallimore, C.I., Iturriza-Gomara, M., Xerry, J., Adigwe, J., Gray, J.J. Inter-seasonal diversity of norovirus genotypes: emergence and selection of virus variants. Arch. Virol. 152, 1295-1303 (2007
51. Harrington, P.R., Vinje, J., Moe, C.L., Baric, R.S. Norovirus capture with histo-blood group antigens reveals novel virus-ligand interactions. J. Virol. 78, 3035-3045 (2004
52. Hutson, A.M., Atmar, R.L., Estes, M.K. Norovirus disease: changing epidemiology and host susceptibility factors. Trends Microbiol. 12, 279-287 (2004
53. Meyer, E., Ebner, W., Scholz, R., Dettenkofer, M., Daschner, F.D. Nosocomial outbreak of norovirus gastroenteritis and investigation of ABO histo-blood group type in infected staff and patients. J. Hosp. Infect. 56, 64-66 (2004
54. Roldao, A., Mellado, M.C., Castilho, L.R., Carrondo, M.J., Alves, P.M. Virus-like particles in vaccine development. Expert Rev. Vaccines 9, 1149-1176 (2010
55. Chackerian, B. Virus-like particles: flexible platforms for vaccine development. Expert Rev. Vaccines 6, 381-390 (2007
56. Tan, M., et al. Mutations within the P2 domain of norovirus capsid affect binding to human histo-blood group antigens: evidence for a binding pocket. J. Virol. 77, 12562-12571 (2003
57. Harrington, P.R., Lindesmith, L., Yount, B., Moe, C.L., Baric, R.S. Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice. J. Virol. 76, 12335-12343 (2002
58. Rockx, B.H., Vennema, H., Hoebe, C.J., Duizer, E., Koopmans, M.P. Association of histo-blood group antigens and susceptibility to norovirus infections. J. Infect. Dis. 191, 749-754 (2005
59. Kovacsovics-Bankowski, M., Clark, K., Benacerraf, B., Rock, K.L. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc. Natl. Acad. Sci. U.S.A. 90, 4942-4946 (1993
60. Bachmann, M.F., et al. Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes. Eur. J. Immunol. 26, 2595-2600 (1996
61. Westhoff, T.H., et al. Chronic norovirus infection in renal transplant recipients. Nephrol. Dial. Transplant. 24, 1051-1053 (2009
62. Gallimore, C.I., Cubitt, D., du Plessis, N., Gray, J.J. Asymptomatic and symptomatic excretion of noroviruses during a hospital outbreak of gastroenteritis. J. Clin. Microbiol. 42, 2271-2274 (2004
63. Asanaka, M., et al. Replication and packaging of Norwalk virus RNA in cultured mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 102, 10327-10332 (2005
64. Schreiber, D.S., Blacklow, N.R., Trier, J.S. The small intestinal lesion induced by Hawaii agent acute infectious nonbacterial gastroenteritis. J. Infect. Dis. 129, 705-708 (1974). doi: 10.1093/infdis/129.6.705
65. Schreiber, D.S., Blacklow, N.R., Trier, J.S. The mucosal lesion of the proximal small intestine in acute infectious nonbacterial gastroenteritis. N. Engl. J. Med. 288, 1318-1323 (1973). doi: 10.1056/NEJM197306212882503
66. Troeger, H., et al. Structural and functional changes of the duodenum in human norovirus infection. Gut 58, 1070-1077 (2009
67. Marionneau, S., et al. Norwalk virus binds to histoblood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology 122, 1967-1977 (2002
68. Harris, J.P., Edmunds, W.J., Pebody, R., Brown, D.W., Lopman, B.A. Deaths from norovirus among the elderly, England and Wales. Emerg. Infect. Dis. 14, 1546-1552 (2008
69. Turcios-Ruiz, R.M., et al. Outbreak of necrotizing enterocolitis caused by norovirus in a neonatal intensive care unit. J. Pediatr. 153, 339-344 (2008
70. Patel, M.M., et al. Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg. Infect. Dis. 14, 1224-1231 (2008
71. Donaldson, E.F., Lindesmith, L.C., Lobue, A.D., Baric, R.S. Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations. Immunol. Rev. 225, 190-211 (2008
72. Koopmans, M. Progress in understanding norovirus epidemiology. Curr. Opin. Infect. Dis. 21, 544-552 (2008
73. Jansen, K. U., Conner, M. E., Estes, M. K. Virus-Like Particles as Vaccines and Vaccine Delivery Systems. In Levine, M. M. (ed) New generation vaccines, Ch. 29, pp. 298-305. Informa Healthcare USA, Inc. (2009
74. Gallimore, C.I., et al. Methods for the detection and characterisation of noroviruses associated with outbreaks of gastroenteritis: outbreaks occurring in the north-west of England during two norovirus seasons. J. Med. Virol. 73, 280-288 (2004
75. Biel, S.S., Gelderblom, H.R. Diagnostic electron microscopy is still a timely and rewarding method. J. Clin. Virol. 13, 105-119 (1999
76. Richards, A.F., et al. Evaluation of a commercial ELISA for detecting Norwalk-like virus antigen in faeces. J. Clin. Virol. 26, 109-115 (2003
77. Atmar, R.L., Estes, M.K. The epidemiologic and clinical importance of norovirus infection. Gastroenterol. Clin. North Am. 35, 275-290 (2006), viii
78. Rabenau, H.F., et al. Laboratory diagnosis of norovirus: which method is the best?. Intervirology 46, 232-238 (2003
79. Gray, J.J., et al. European multicenter evaluation of commercial enzyme immunoassays for detecting norovirus antigen in fecal samples. Clin. Vaccine Immunol. 14, 1349-1355 (2007
80. de Bruin, E., Duizer, E., Vennema, H., Koopmans, M.P. Diagnosis of Norovirus outbreaks by commercial ELISA or RT-PCR. J. Virol. Methods 137, 259-264 (2006
81. Moore, C., et al. Evaluation of a broadly reactive nucleic acid sequence based amplification assay for the detection of noroviruses in faecal material. J. Clin. Virol. 29, 290-296 (2004
82. Amar, C.F., et al. Detection by PCR of eight groups of enteric pathogens in 4, 627 faecal samples: reexamination of the English case-control Infectious Intestinal Disease Study (1993-1996). Eur. J. Clin. Microbiol. Infect. Dis. 26, 311-323 (2007
83. Vinje, J., et al. International collaborative study to compare reverse transcriptase PCR assays for detection and genotyping of noroviruses. J. Clin. Microbiol. 41, 1423-1433 (2003
84. Fankhauser, R.L., et al. Epidemiologic and molecular trends of Norwalk-like viruses associated with outbreaks of gastroenteritis in the United States. J. Infect. Dis. 186, 1-7 (2002). doi: 10.1086/341085
85. Medici, M.C., et al. Broadly reactive nested reverse transcription-PCR using an internal RNA standard control for detection of noroviruses in stool samples. J. Clin. Microbiol. 43, 3772-3778 (2005). doi: 10.1128/jcm.43.8.3772-3778.2005
86. Trujillo, A.A., et al. Use of TaqMan real-Time reverse transcription-PCR for rapid detection, quantification, and typing of norovirus. J. Clin. Microbiol. 44, 1405-1412 (2006
87. Gunson, R.N., Carman, W.F. Comparison of two real-Time PCR methods for diagnosis of norovirus infection in outbreak and community settings. J. Clin. Microbiol. 43, 2030-2031 (2005
88. Dowell, S.F., et al. A multistate outbreak of oysterassociated gastroenteritis: implications for interstate tracing of contaminated shellfish. J. Infect. Dis. 171, 1497-1503 (1995). doi: 10.1093/infdis/171.6.1497
89. Parashar, U.D., et al. An outbreak of viral gastroenteritis associated with consumption of sandwiches: implications for the control of transmission by food handlers. Epidemiol. Infect. 121, 615-621 (1998
90. Fisman, D.N., Greer, A.L., Brouhanski, G., Drews, S.J. Of gastro and the gold standard: evaluation and policy implications of norovirus test performance for outbreak detection. J. Transl. Med. 7, 23 (2009
91. Hansman, G.S., et al. Structural basis for norovirus inhibition and fucose mimicry by citrate. J. Virol. 86, 284-292 (2012). doi: 10.1128/jvi.05909-11
92. Parrino, T.A., Schreiber, D.S., Trier, J.S., Kapikian, A.Z., Blacklow, N.R. Clinical immunity in acute gastroenteritis caused by Norwalk agent. N. Engl. J. Med. 297, 86-89 (1977
93. Johnson, P.C., Mathewson, J.J., DuPont, H.L., Greenberg, H.B. Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults. J. Infect. Dis. 161, 18-21 (1990
94. Matsui, S.M., Greenberg, H.B. Immunity to calicivirus infection. J. Infect. Dis. 181 (Suppl 2), S331-S335 (2000
95. Lindesmith, L., et al. Human susceptibility and resistance to Norwalk virus infection. Nat. Med. 9, 548-553 (2003
96. Fifis, T., et al. Size-dependent immunogenicity: therapeutic and protective properties of nanovaccines against tumors. J. Immunol. 173, 3148-3154 (2004
97. Bachmann, M.F., et al. The infl uence of antigen organization on B cell responsiveness. Science 262, 1448-1451 (1993
98. Bachmann, M.F., Zinkernagel, R.M. The infl uence of virus structure on antibody responses and virus serotype formation. Immunol. Today 17, 553-558 (1996
99. Fehr, T., Skrastina, D., Pumpens, P., Zinkernagel, R.M. T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles. Proc. Natl. Acad. Sci. U.S.A. 95, 9477-9481 (1998
100. Bachmann, M.F., Zinkernagel, R.M. Neutralizing antiviral B cell responses. Annu. Rev. Immunol. 15, 235-270 (1997
101. Santi, L., Huang, Z., Mason, H. Virus-like particles production in green plants. Methods 40, 66-76 (2006
102. Chen, Q., et al. Subunit Vaccines Producing Using Plant Biotechnology. In Levine M. M. (ed) New generation vaccines, Ch. 30, pp. 306-315. Informa Healthcare USA, Inc. (2009
103. Herbst-Kralovetz, M., Mason, H.S., Chen, Q. Norwalk virus-like particles as vaccines. Expert Rev. Vaccines 9, 299-307 (2010). doi: 10.1586/erv.09.163
104. Prasad, B.V., Rothnagel, R., Jiang, X., Estes, M.K. Three-dimensional structure of baculovirusexpressed Norwalk virus capsids. J. Virol. 68, 5117-5125 (1994
105. Baric, R.S., et al. Expression and self-Assembly of Norwalk virus capsid protein from Venezuelan equine encephalitis virus replicons. J. Virol. 76, 3023-3030 (2002
106. Jiang, X., Wang, M., Graham, D.Y., Estes, M.K. Expression, self-Assembly, and antigenicity of the Norwalk virus capsid protein. J. Virol. 66, 6527-6532 (1992
107. Ausar, S.F., Foubert, T.R., Hudson, M.H., Vedvick, T.S., Middaugh, C.R. Conformational stability and disassembly of Norwalk virus like particles: effect of pH and temperature. J. Biol. Chem. 281, 19478-19488 (2006). doi: 10.1074/jbc.M603313200
108. Prasad, B.V.V., Hardy, D., Estes, M. Structural studies of recombinant Norwalk capsids. J. Infect. Dis. 181, S317-S321 (2000). doi: 10.1086/315576
109. Tan, M., Jiang, X. The p domain of norovirus capsid protein forms a subviral particle that binds to histoblood group antigen receptors. J. Virol. 79, 14017-14030 (2005
110. Tan, M., Zhong, W., Song, D., Thornton, S., Jiang, X. E. coli-expressed recombinant norovirus capsid proteins maintain authentic antigenicity and receptor binding capability. J. Med. Virol. 74, 641-649 (2004
111. Tan, M., Meller, J., Jiang, X. C-Terminal arginine cluster is essential for receptor binding of norovirus capsid protein. J. Virol. 80, 7322-7331 (2006
112. Cao, S., et al. Structural basis for the recognition of blood group trisaccharides by norovirus. J. Virol. 81, 5949-5957 (2007
113. Pushko, P., et al. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Virology 239, 389-401 (1997
114. Guerrero, R.A., et al. Recombinant Norwalk viruslike particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses. J. Virol. 75, 9713-9722 (2001
115. LoBue, A.D., et al. Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains. Vaccine 24, 5220-5234 (2006
116. Pushko, P., et al. Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus. Vaccine 19, 142-153 (2000
117. Harrington, P.R., et al. Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles. J. Virol. 76, 730-742 (2002
118. LoBue, A.D., Lindesmith, L.C., Baric, R.S. Identification of cross-reactive norovirus CD4+ T cell epitopes. J. Virol. 84, 8530-8538 (2010
119. LoBue, A.D., Thompson, J.M., Lindesmith, L., Johnston, R.E., Baric, R.S. Alphavirus-Adjuvanted norovirus-like particle vaccines: heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge. J. Virol. 83, 3212-3227 (2009
120. Davis, N.L., Brown, K.W., Johnston, R.E. A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge. J. Virol. 70, 3781-3787 (1996
121. MacDonald, G.H., Johnston, R.E. Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis. J. Virol. 74, 914-922 (2000
122. Thompson, J.M., et al. Mucosal and systemic adjuvant activity of alphavirus replicon particles. Proc. Natl. Acad. Sci. U.S.A. 103, 3722-3727 (2006
123. Chen, Q. Expression and purification of pharmaceutical proteins in plants. Biol. Eng. 1, 291-321 (2008
124. Chen, Q. Mou, B., Scorza, R. (eds) Transgenic horticultural crops: Expression and Manufacture of Pharmaceutical Proteins in Genetically Engineered Horticultural Plants challenges and opportunities-essays by experts, Ch. 4, pp. 83-124. Taylor & Francis (2011
125. Chen, Q. Turning a new leaf. European Biopharm. Rev. 2, 64-68 (2011
126. Lai, H., Chen, Q. Bioprocessing of plant-derived virus-like particles of Norwalk virus capsid protein under current Good Manufacture Practice regulations. Plant Cell Rep. 31, 573-584 (2012
127. Faye, L., Gomord, V. Success stories in molecular farming-A brief overview. Plant Biotechnol. J. 8, 525-528 (2010
128. Lai, H., et al. Monoclonal antibody produced in plants efficiently treats West Nile virus infection in mice. Proc. Natl. Acad. Sci. U.S.A. 107, 2419-2424 (2010). doi: 10.1073/pnas.0914503107
129. Lai, H., He, J., Engle, M., Diamond, M.S., Chen, Q. Robust production of virus-like particles and monoclonal antibodies with geminiviral replicon vectors in lettuce. Plant Biotechnol. J. 10, 95-104 (2012
130. Komarova, T.V., et al. Transient expression systems for plant-derived biopharmaceuticals. Expert Rev. Vaccines 9, 859-876 (2010). doi: 10.1586/erv.10.85
131. Lico, C., Chen, Q., Santi, L. Viral vectors for production of recombinant proteins in plants. J. Cell. Physiol. 216, 366-377 (2008
132. Huang, Z., Chen, Q., Hjelm, B., Arntzen, C., Mason, H. A DNA replicon system for rapid high-level production of virus-like particles in plants. Biotechnol. Bioeng. 103, 706-714 (2009
133. Santi, L., et al. An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles. Vaccine 26, 1846-1854 (2008
134. He, J., Lai, H., Brock, C., Chen, Q. A novel system for rapid and cost-effective production of detection and diagnostic reagents of west Nile virus in plants. J. Biomed. Biotechnol. 2012, 1-10 (2012). doi: 10.1155/2012/106783
135. Tacket, C.O., Pasetti, M.F., Edelman, R., Howard, J.A., Streatfield, S. Immunogenicity of recombinant LT-B delivered orally to humans in transgenic corn. Vaccine 22, 4385-4389 (2004
136. Kapusta, J., et al. A plant-derived edible vaccine against hepatitis B virus. FASEB J. 13, 1796-1799 (1999
137. Yusibov, V., et al. Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine. Vaccine 20, 3155-3164 (2002
138. Zhang, X., Buehner, N.A., Hutson, A.M., Estes, M.K., Mason, H.S. Tomato is a highly effective vehicle for expression and oral immunization with Norwalk virus capsid protein. Plant Biotechnol. J. 4, 419-432 (2006
139. Huang, Z., et al. Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses. Vaccine 23, 1851-1858 (2005
140. Huang, Z., et al. High-level rapid production of fullsize monoclonal antibodies in plants by a singlevector DNA replicon system. Biotechnol. Bioeng. 106, 9-17 (2010
141. Giritch, A., et al. Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors. Proc. Natl. Acad. Sci. U.S.A. 103, 14701-14706 (2006
142. Marillonnet, S., et al. In planta engineering of viral RNA replicons: efficient assembly by recombination of DNA modules delivered by Agrobacterium. Proc. Natl. Acad. Sci. U.S.A. 101, 6852-6857 (2004
143. Chen, Q., He, J., Phoolcharoen, W., Mason, H.S. Geminiviral vectors based on bean yellow dwarf virus for production of vaccine antigens and monoclonal antibodies in plants. Hum. Vaccin. 7, 331-338 (2011
144. Tacket, C.O., Sztein, M.B., Losonsky, G.A., Wasserman, S.S., Estes, M.K. Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers. Clin. Immunol. 108, 241-247 (2003
145. Rolland, D., et al. Purification of recombinant HBc antigen expressed in Escherichia coli and Pichia pastoris: comparison of size-exclusion chromatography and ultracentrifugation. J. Chromatogr. B Biomed. Sci. Appl. 753, 51-65 (2001
146. Rodrigues, T., et al. Screening anion-exchange chromatographic matrices for isolation of oncoretroviral vectors. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 837, 59-68 (2006
147. Ball, J.M., et al. Recombinant Norwalk virus-like particles as an oral vaccine. Arch. Virol. Suppl. 12, 243-249 (1996
148. El-Kamary, S.S., et al. Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues. J. Infect. Dis. 202, 1649-1658 (2010). doi: 10.1086/657087
149. Tacket, C.O., et al. Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes. J. Infect. Dis. 182, 302-305 (2000
150. Frenck, R., et al. Predicting susceptibility to norovirus GII.4 by use of a challenge model involving humans. J. Infect. Dis. 206 (9), 1386-1393 (2012). doi: 10.1093/infdis/jis514